{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:34:51Z","timestamp":1759332891478,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.imbio.2022.152287","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T11:52:06Z","timestamp":1664365926000},"page":"152287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bioinformatics-based SARS-CoV-2 epitopes design and the impact of spike protein mutants on epitope humoral immunities"],"prefix":"10.1016","volume":"227","author":[{"given":"Qi","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuanqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenghua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2022.152287_b0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.2021.8565","article-title":"Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial","volume":"326","author":"Al Kaabi","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.imbio.2022.152287_b0010","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1038\/s41598-017-09199-w","article-title":"Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection","volume":"7","author":"Ali","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.imbio.2022.152287_b0015","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/jmv.25736","article-title":"Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach","volume":"92","author":"Bhattacharya","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.imbio.2022.152287_b0020","first-page":"3409","article-title":"Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment","volume":"39","author":"Boopathi","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.imbio.2022.152287_b0025","doi-asserted-by":"crossref","unstructured":"Huynh-Hoa Bui, John Sidney, Kenny Dinh, et al. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. Bmc Bioinformatics 2006;7,doi:10.1186\/1471-2105-7-153.","DOI":"10.1186\/1471-2105-7-153"},{"key":"10.1016\/j.imbio.2022.152287_b0030","doi-asserted-by":"crossref","first-page":"e1003266","DOI":"10.1371\/journal.pcbi.1003266","article-title":"Properties of MHC Class I Presented Peptides That Enhance Immunogenicity","volume":"9","author":"Calis","year":"2013","journal-title":"Plos Comput. Biol."},{"key":"10.1016\/j.imbio.2022.152287_b0035","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2022.152287_b0040","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3389\/fimmu.2019.01081","article-title":"HLA-Class II Artificial Antigen Presenting Cells in CD4(+) T Cell-Based Immunotherapy","volume":"10","author":"Couture","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2022.152287_b0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1440-1711.2002.01092.x","article-title":"Immuno-informatics: Mining genomes for vaccine components [J\/OL]","volume":"80","author":"De Groot","year":"2002","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.imbio.2022.152287_b0050","doi-asserted-by":"crossref","unstructured":"Deng, X., Garcia-Knight, M. A., Khalid, M. M., et al., 2021, Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation. medRxiv, doi:10.1101\/2021.03.07.21252647.","DOI":"10.1101\/2021.03.07.21252647"},{"key":"10.1016\/j.imbio.2022.152287_b0055","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/263952","article-title":"Prediction of IL4 Inducing Peptides","volume":"2013","author":"Dhanda","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.imbio.2022.152287_b0060","first-page":"8","article-title":"Designing of interferon-gamma inducing MHCclass-II binders","author":"Dhanda","year":"2013","journal-title":"Biol. Direct"},{"key":"10.1016\/j.imbio.2022.152287_b0065","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP vol 2-a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.imbio.2022.152287_b0070","doi-asserted-by":"crossref","unstructured":"Doytchinova, I. A., Flower, D. R., 2007. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. Bmc Bioinformatics 8, doi:10.1186\/1471-2105-8-4.","DOI":"10.1186\/1471-2105-8-4"},{"key":"10.1016\/j.imbio.2022.152287_b0075","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.vaccine.2006.09.032","article-title":"Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties","volume":"25","author":"Doytchinova","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2022.152287_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jmr.893","article-title":"Predicting linear B-cell epitopes using string kernels","volume":"21","author":"El-Manzalawy","year":"2008","journal-title":"J. Mol. Recog."},{"key":"10.1016\/j.imbio.2022.152287_b0085","doi-asserted-by":"crossref","unstructured":"Jonathan M. Gershoni, A. R.-B., Dror D. Siman-Tov, Natalia Tarnovitski Freund and, Weiss, Y. Epitope mapping: the first step in developing epitope-based vaccines. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 2007;21:145-146, doi:10.2165\/00063030-200721030-00002.","DOI":"10.2165\/00063030-200721030-00002"},{"key":"10.1016\/j.imbio.2022.152287_b0090","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.chom.2020.03.002","article-title":"A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2","volume":"27","author":"Grifoni","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.imbio.2022.152287_b0095","doi-asserted-by":"crossref","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","article-title":"In Silico Approach for Predicting Toxicity of Peptides and Proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imbio.2022.152287_b0100","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.4049\/jimmunol.173.6.4050","article-title":"Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines","volume":"173","author":"He","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2022.152287_b0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/tan.13358","article-title":"HLA common and well-documented alleles in China","volume":"92","author":"He","year":"2018","journal-title":"HLA"},{"key":"10.1016\/j.imbio.2022.152287_b0110","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.abc4730","article-title":"Adaptation of SARS-CoV-2 in BALB c mice fortesting vaccine efficacy","volume":"369","author":"Hongjing","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.imbio.2022.152287_b0115","first-page":"1895","article-title":"Thermostability and Aliphatic Index of Globular Proteins","volume":"88","author":"Ikai","year":"1980","journal-title":"J. Biochem."},{"key":"10.1016\/j.imbio.2022.152287_b0120","doi-asserted-by":"crossref","unstructured":"Irini A. Doytchinova*, a. D. R. F. Bioinformatic Approach for Identifying Parasite and Fungal Candidate Subunit Vaccines. The Open Vaccine Journal 2008;1:22-26, doi:10.2174\/1875035400801010022.","DOI":"10.2174\/1875035400801010022"},{"key":"10.1016\/j.imbio.2022.152287_b0125","first-page":"1","article-title":"Prediction of Epitope based Peptides for Vaccine Development from Complete Proteome of Novel Corona Virus (SARS-COV-2) Using Immunoinformatics","author":"Jain","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.imbio.2022.152287_b0130","doi-asserted-by":"crossref","unstructured":"Jespersen, M. C., Peters, B., Nielsen, M., et al., 2017, BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res; 45:W24-W29, doi:10.1093\/nar\/gkx346.","DOI":"10.1093\/nar\/gkx346"},{"key":"10.1016\/j.imbio.2022.152287_b0135","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41467-020-20321-x","article-title":"Stabilizing the Closed SARS-CoV-2 Spike Trimer","volume":"12","author":"Juraszek","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imbio.2022.152287_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104236","article-title":"Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2","volume":"145","author":"Kalita","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.imbio.2022.152287_b0145","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","article-title":"Phase 1\u20132 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine","volume":"383","author":"Keech","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2022.152287_b0150","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s10038-020-0771-5","article-title":"Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2","volume":"65","author":"Kiyotani","year":"2020","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.imbio.2022.152287_b0155","doi-asserted-by":"crossref","unstructured":"Korber, B., Fischer, W. M., Gnanakaran, S., et al., 2020, Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell; 182:812-827 e819, doi:10.1016\/j.cell.2020.06.043.","DOI":"10.1016\/j.cell.2020.06.043"},{"key":"10.1016\/j.imbio.2022.152287_b0160","doi-asserted-by":"crossref","unstructured":"Lopez Bernal, J., Andrews, N., Gower, C., et al., 2021, Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. N Engl J Med; 385:585-594, doi:10.1056\/NEJMoa2108891.","DOI":"10.1056\/NEJMoa2108891"},{"key":"10.1016\/j.imbio.2022.152287_b0165","doi-asserted-by":"crossref","unstructured":"Manavalan, B., Govindaraj, R. G., Shin, T. H., et al., 2018, iBCE-EL: A New Ensemble Learning Framework for Improved Linear B-Cell Epitope Prediction. Frontiers in Immunology; 9, doi:10.3389\/fimmu.2018.01695.","DOI":"10.3389\/fimmu.2018.01695"},{"issue":"8","key":"10.1016\/j.imbio.2022.152287_b0170","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3390\/v6082991","article-title":"The coronavirus nucleocapsid is a multifunctional protein [J\/OL]","volume":"6","author":"Mcbride","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.imbio.2022.152287_b0175","doi-asserted-by":"crossref","unstructured":"Nevagi, R.J., Toth I, M, S. Peptide Applications in Biomedicine, Biotechnology and Bioengineering. 2018, doi:10.2165\/00063030-200721030-00002.","DOI":"10.2165\/00063030-200721030-00002"},{"key":"10.1016\/j.imbio.2022.152287_b0180","doi-asserted-by":"crossref","unstructured":"Nielsen, M., Andreatta, M. NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets. Genome Med 2016;8:33, doi:10.1186\/s13073-016-0288-x.","DOI":"10.1186\/s13073-016-0288-x"},{"key":"10.1016\/j.imbio.2022.152287_b0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.immuni.2021.01.014","article-title":"B cell memory: understanding COVID-19","volume":"54","author":"Quast","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2022.152287_b0190","doi-asserted-by":"crossref","unstructured":"Reynisson, B., Alvarez, B., Paul, S., et al., 2020, NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res; 48:W449-W454, doi:10.1093\/nar\/gkaa379.","DOI":"10.1093\/nar\/gkaa379"},{"key":"10.1016\/j.imbio.2022.152287_b0195","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1016\/j.vaccine.2020.10.016","article-title":"Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches","volume":"38","author":"Safavi","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2022.152287_b0200","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.imbio.2022.152287_b0205","doi-asserted-by":"crossref","unstructured":"Sahin, U., Muik, A., Derhovanessian, E., et al., 2020, Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine., doi:10.1101\/2020.07.17.20140533.","DOI":"10.1101\/2020.07.17.20140533"},{"key":"10.1016\/j.imbio.2022.152287_b0215","doi-asserted-by":"crossref","unstructured":"Starr, T. N., Greaney, A. J., Hilton, S. K., et al., 2020, Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell; 182:1295-1310 e1220, doi:10.1016\/j.cell.2020.08.012.","DOI":"10.1016\/j.cell.2020.08.012"},{"key":"10.1016\/j.imbio.2022.152287_b0220","first-page":"531","article-title":"Protein identification and analysis tools in the ExPASy server","volume":"112","author":"Wilkins","year":"1999","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.imbio.2022.152287_b0225","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respiratory Med."},{"key":"10.1016\/j.imbio.2022.152287_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.565278","article-title":"Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.imbio.2022.152287_b0235","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/vaccines8020153","article-title":"Progress and Prospects on Vaccine Development against SARS-CoV-2 [J\/OL]","volume":"8","author":"Zhang","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.imbio.2022.152287_b0240","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.imbio.2022.152287_b0245","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298522001139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298522001139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:50:52Z","timestamp":1759251052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298522001139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0171298522001139"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2022.152287","relation":{},"ISSN":["0171-2985"],"issn-type":[{"type":"print","value":"0171-2985"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioinformatics-based SARS-CoV-2 epitopes design and the impact of spike protein mutants on epitope humoral immunities","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2022.152287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152287"}}